Logo image of VATE

INNOVATE CORP (VATE) Stock Fundamental Analysis

USA - NYSE:VATE - US45784J3032 - Common Stock

4.61 USD
-0.05 (-1.07%)
Last: 10/15/2025, 12:40:32 PM
Fundamental Rating

2

Overall VATE gets a fundamental rating of 2 out of 10. We evaluated VATE against 54 industry peers in the Construction & Engineering industry. VATE may be in some trouble as it scores bad on both profitability and health. VATE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year VATE has reported negative net income.
In the past year VATE had a positive cash flow from operations.
In the past 5 years VATE always reported negative net income.
VATE had a positive operating cash flow in 4 of the past 5 years.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.87%, VATE is doing worse than 81.48% of the companies in the same industry.
VATE's Return On Invested Capital of 91.87% is amongst the best of the industry. VATE outperforms 98.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VATE is significantly below the industry average of 17.10%.
The 3 year average ROIC (4.95%) for VATE is below the current ROIC(91.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.87%
ROE N/A
ROIC 91.87%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Operating Margin, with a value of 2.08%, VATE is doing worse than 62.96% of the companies in the same industry.
In the last couple of years the Operating Margin of VATE has declined.
VATE has a Gross Margin (18.66%) which is comparable to the rest of the industry.
VATE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.08%
PM (TTM) N/A
GM 18.66%
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

VATE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, VATE has more shares outstanding
Compared to 5 years ago, VATE has less shares outstanding
The debt/assets ratio for VATE is higher compared to a year ago.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

VATE has an Altman-Z score of -0.30. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.
VATE's Altman-Z score of -0.30 is on the low side compared to the rest of the industry. VATE is outperformed by 85.19% of its industry peers.
VATE has a debt to FCF ratio of 35.03. This is a negative value and a sign of low solvency as VATE would need 35.03 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 35.03, VATE is in line with its industry, outperforming 42.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 35.03
Altman-Z -0.3
ROIC/WACC14.29
WACC6.43%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

VATE has a Current Ratio of 0.46. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
VATE's Current ratio of 0.46 is on the low side compared to the rest of the industry. VATE is outperformed by 87.04% of its industry peers.
VATE has a Quick Ratio of 0.46. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of VATE (0.43) is worse than 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.43
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VATE have decreased strongly by -975.53% in the last year.
VATE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.08%.
Measured over the past years, VATE shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-975.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1770%
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%-22.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2023 0 10 -10 20 30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

VATE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VATE is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, VATE is valued cheaper than 98.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.38
EV/EBITDA 12.77
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VATE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATE CORP

NYSE:VATE (10/15/2025, 12:40:32 PM)

4.61

-0.05 (-1.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04
Inst Owners19.58%
Inst Owner Change0%
Ins Owners52.99%
Ins Owner Change12.26%
Market Cap61.50M
Analysts82.86
Price TargetN/A
Short Float %7.06%
Short Ratio11.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)0.76%
DP-2.15%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 3.38
P/OCF 1.56
P/B N/A
P/tB N/A
EV/EBITDA 12.77
EPS(TTM)-6.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.36
FCFY29.59%
OCF(TTM)2.95
OCFY63.91%
SpS74.59
BVpS-15.57
TBVpS-37.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.87%
ROE N/A
ROCE 116.29%
ROIC 91.87%
ROICexc N/A
ROICexgc N/A
OM 2.08%
PM (TTM) N/A
GM 18.66%
FCFM 1.83%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
ROICexc(3y)5.63%
ROICexc(5y)N/A
ROICexgc(3y)24.72%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 35.03
Debt/EBITDA 3.07
Cap/Depr 66.98%
Cap/Sales 2.12%
Interest Coverage 0.42
Cash Conversion 75.29%
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.43
Altman-Z -0.3
F-Score4
WACC6.43%
ROIC/WACC14.29
Cap/Depr(3y)52.64%
Cap/Depr(5y)57.69%
Cap/Sales(3y)1.42%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-975.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1770%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%-22.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.03%
EBIT growth 3YN/A
EBIT growth 5Y-8.4%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y138.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y242.39%
OCF growth 3Y-65.54%
OCF growth 5Y-39.31%